Nothing said here yet.
to join the conversation.
British American Tobacco recently continued its share buyback programme and warned that criminal syndicates now control much of South Africa’s illicit tobacco market, prompting plans to cease local production as legal cigarettes lose ground to contraband.
Key TakeawaysVerizon yields 6. 8% after an 8.
Key TakeawaysPfizer yields 6. 3% and British American Tobacco 6.
Key TakeawaysRealty Income and British American Tobacco both yield 6. 1%, so $10,000 in either pays $610 a year today.
Key TakeawaysKraft Heinz yields 7. 2% and British American Tobacco yields 6.
Key TakeawaysGeneral Mills yields 7. 7% and British American Tobacco yields 6.
British American Tobacco p.l.c. (NYSE:BTI) offers its cigarettes, tobacco-heating products, vapes, and nicotine pouches under brand names such as Dunhill, Newport, Vuse, and Velo.
British American Tobacco has delivered a powerful 128.2% share price gain over the past 5 years, yet the recent pullback and regulatory noise now put a sharper spotlight on whether that run still matches up with the earnings behind it.
Event overview and why British American Tobacco is back in focus British American Tobacco (LSE:BATS) reaffirmed its 2026 outlook, telling investors it expects full year revenue growth at the lower end of its 3% to 5% guidance range.
British American Tobacco (NYSE:BTI) outlined its Horizon 2030 strategy at its 2026 Capital Markets Day, targeting growth in smokeless nicotine products while maintaining combustibles as a cash-generating business that funds investment, dividends and share buybacks.
British American Tobacco (NYSE:BTI) used its 2026 Capital Markets Day to outline its Horizon 2030 strategy, emphasizing growth in modern oral nicotine products, a turnaround in the U.S. business, continued cash generation from combustibles and greater use of…
British American Tobacco (NYSE:BTI) used its Horizon 2030 Capital Markets Day in Winston-Salem, North Carolina, to outline plans to expand its smokeless portfolio, advocate for tobacco harm reduction regulation and deliver growth, margin expansion and shareholder returns through 2030.